Changes of dopamine-beta-hydroxylase activity during ontogenesis in healthy subjects and in an experimental model (rats)

Physiological Research

Volumn 53, Issue 6, 2004, Pages 661-667

  Paclt, I ^a   Koudelova J ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Developmental changes; Dopamine beta hydroxylase (DBH); Human; Noradrenergic system; Rats; Serum

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPMENT; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORADRENERGIC SYSTEM; NORMAL HUMAN; ONTOGENY; PUBERTY; RAT; STATISTICAL ANALYSIS;

ADOLESCENT; AGING; ANIMALS; CHILD; CHILD, PRESCHOOL; DOPAMINE BETA-HYDROXYLASE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; RATS; RATS, WISTAR; SEX FACTORS;

EID: 11244333664     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 11C-raxlopride. Ann N Y Acad Sci 695: 81-85, 1993.
2. BEHRENS WA, DEPOCAS F: Dopamine beta-hydroxylase in rat serum and lymph: changes with age and effect of cold exposure. Can J Physiol Pharmacol 53: 1080-1088, 1975.
3. CIARANELLO RD, BOEHME RE: Biochemical genetics of neurotransmitter enzymes and receptors and relationships to schizophrenia and other major psychiatric disorders, Clin Genet 19: 358-372, 1981.
4. COHEN DJ, CAPARULO BK, JOHNSON WT, BOWERS MB: Biogenic amines in autistic and atypical children: Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 31: 845-853, 1974.
5. CUBELLS JF, KRANZLER HR, McCANCE-KATZ E, ANDERSON GM, MALISON RT, PRICE LH, GELERNTER J: A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity also associates with cocaine-induced paranoia. Mol Psychiatry 5: 56-63, 2000.
6. CUBELLS, JF, PRICE LH, MEYERS BS, ANDERSON GM, ZABETIAN CP, ALEXOPOULOS GS, NELSON JC, SANACORA G, KIRWIN P, CARPENTER L, MALISON RT, GELERNTER J: Genotype-controlled analysis of plasma dopamine-beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 51: 358-364, 2002.
7. DRTÍLKOVÁ I: SSSRI antidepressive drugs in pedopsychiatry (in Czech). In: Second Czecho-Slovak Symposium, Český Krumlov May 28-30, 1999.
8. FREEDMAN LS, OHUCHL T, GOLDSTEIN M, ASELROD F, FICH I, DAUCIS J: Changes in human serum dopamine-hydroxylase activity with age. Nature 236: 310-311, 1972.
9. FUJITA K, MARUTA K, TERADAIRA R, BEPPU H, IKEGAME M, KAWAI K: Dopamine-beta-hydroxylase activity in human cerebrospinal fluid from various age groups. Clin Chem 28: 1403-1404, 1982.
10. GEFFEN LD, RUSH RA, LOUIS WJ, DOYLE AE: Plasma dopamine-beta-hydroxylase and noradrenaline amount in essential hypertension. Clin. Sci. 44, 617-620, 1973.
11. GERRING IP, GRADY RD, CHEN A, VASA R, GRADOS M, BANDEEN-ROCHE KJ, BRYAN RN, DENCKLA MB: Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. J Am Child Adolesc Psychiatry 17: 647-654, 1998.
12. GOTTFRIES CG, ROOS RE, WINBLOD B: Determination of 5-hydroxytryptamine in brain tissue from autopsy material. Acta Psychiatr Scand 50: 496-507, 1975.
13. KATO T, IKUTA K, TAKAHASHI K, NAGATSU T: Changes in dopamine-beta- hydroxylase activity of monkey plasma with age. Experientia 32: 834-835, 1975.
14. LAMPRECHT F, WOOTEN GF: Serum dopamine-beta-hydroxylase activity in rat during postnatal development. J Neural Transtn 39: 301-307, 1976.
15. LECKMAN JF, COHEN DJ, SHAYWITZ BA, CAPARUIO BJ, HENINGER GR, BOWERS MD: CSF monoamine metabolism in child and adult psychiatric patients. A developmental perspective. Arch Gen Psychiatry 37: 677-861, 1980.
16. LEWIS DA, HAYES TL, LUND JS, OETH KM: Dopamine and the neural circuitry of primate prefrontal cortex: implications for schizophrenia research. Neuropsychopharmacology 6: 127-134, 1992.
17. NAGATSU T, UDENFRIEND S: Photometric assay of dopamine-beta-hydroxylase activity in human blood. Clin Chem 18: 980-983, 1972.
18. NAGATSU T, KATO T, NUMATA Y, IKUTA K, UMEZAWA H, MATSUZAKI M, TAKEUCHI T: Serum dopamine-beta-hydroxylase activity in developing hypertensive rats. Nature 251: 630-631, 1974.
19. OGIHARA T, NUGENT CHA, SHEN S-W, GOLDFEIN S: Serum dopamine-beta- hydroxylase activity in parents and children. J Lab Clin Med 85: 566-573,1974.
20. PACLT I, KOUDELOVÁ J: Dopamine-beta-hydroxylase activity in some neuropsychiatric disorders during childhood. Sixth ESN General Meeting, Prague, 1986.
21. PACLT I, KOUDELOVÁ J: The activity of the dopamine beta hydroxylase (DBH) in experimental animals in norm and in humans suffering with special developmental dopaminergic disturbance. IBCs International Conference on Dopaminergic Disorders, April 28-29, 1997, Boston.
22. PACLT I, FLORIAN J: Psychopharmacology of Childhood and Adolescents. Grada, Publishing, 1998, 408 p.
23. PLANZ G., PALM D.: Acute enhancement of dopamine beta hydroxylase activity in human plasma after maximum work load. Eur J. Clin Pharmacol 5: 255-258, 1973.
24. RAPPAPORT J, QUINN P, LAMBRECHT F: Minor physical anomalies and plasma dopamine-beta-hydroxylase activity in hyperactive boys. Am J Psychiatry 131: 386-390,1974.
25. ROBINSON PD, SCHUTZ CK, MACCIARDI F, WHITE BN, HOLDEN JJA: Genetically determined low maternal serum dopamine hydroxylase levels and the etiology of autism spectrum disorders. Am J Med Genet 100: 30-36, 2001.
26. SEEMAN P, BZOWEJ NH, GUAN HC, BERGERON C, BECKER LE, REYNOLDS GP, BIRD ED, RIEDERER P, JELLINGER K, WATANABE S, TOURTELLOTTE WW: Human brain dopamine receptors in children and aging adults. Synapse 1: 399-404, 1987.
27. SUZUKI H, SHIMOHIRA M, IWAKAWA Y, NAGATSU T: Developmental change of dopamine beta-hydroxylase activity in cerebrospinal fluid of epileptic and non-epileptic children. J Neural Transm Gen Sec 80: 225-230, 1990.
28. WEINSHILBOUM RM: Serum dopamine beta-hydroxylase. Pharmacol Rev 30: 133-133, 1979.
29. WEINSHILBOUM RM, AXELROD J: Reduced plasma dopamine-beta-hydroxylase activity in familial dysautonomia. N Engl J Med 285: 938-942, 1971.
30. WEINSHILBOUM RM, RAYMOND FA, ELVEBACK LR, WEIDMAN HW: Serum dopamine-beta-hydroxylase activity: sibling-sibling correlation. Science 181: 943-945, 1973a
31. WEINSHILBOUM RM, RAYMOND FA, ELVEBACK LR: A twin study on three enzymes (DBH, COMT, MAO) of catecholamine metabolism. Correlations with MMPI. Psychopharmacology 57: 63-69, 1973b.
32. WIGG K, ZAI G, SCHACHER R, TANNOCK R, ROBERTS W, MALONE M, KENNEDY JL, BARR CL: Attention deficit hyperactivity disorder and the gene for dopamine beta-hydroxylase. Am J Psychiat 159: 1046-1048, 2002.
33. WOOD JG, JOYCE PR, MILLER AL, MULDER RT, KENNEDY MA: A polymorphism in the dopamine beta-hydroxylase gene is associated with "paranoid ideation" in patients with major depression. Biol Psychiat 51: 365-369, 2002.
34. YOUNG JG, KYPRIE RM, ROSS NT, COHEN DJ: Serum dopamine-beta-hydroxylase activity: clinical applications in child psychiatry. J Autism Dev Disord 10: 1-14, 1980.
35. ZIEGLER MC, LAKE CR, KOPIN IJ: Plasma norepinephrine increases with age. Nature 261: 333-335, 1976.